Prevention and treatment of meningitis and acute otitis media in children with cochlear implants

Otology and Neurotology

Volumn 31, Issue 8, 2010, Pages 1331-1333

  Rubin, Lorry G ^a,b  

^a Northwell Health   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cochlear implants; Meningitis; Otitis media

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT;

BACTERIAL MENINGITIS; CHILD; COCHLEA PROSTHESIS; HUMAN; IMPLANTATION; MICROBIOLOGY; OTITIS MEDIA; PNEUMOCOCCAL INFECTION; POLICY; REVIEW; VACCINATION;

AMOXICILLIN; ANTI-INFECTIVE AGENTS; CHILD; COCHLEAR IMPLANTATION; COCHLEAR IMPLANTS; HUMANS; MENINGITIS, BACTERIAL; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; POLICY; VACCINATION;

EID: 77958102416     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e3181f2f074     Document Type: Conference Paper

References (11)

1. National Institute on Deafness and Other Communication Disorders, National Institutes of Health. Cochlear Implants. Available at: http://www.nidcd.nih.gov/health/hearing/coch.asp. Accessed April 14, 2009.
2. Dettman SJ, Pinder D, Briggs RJ, Dowell RC, Leigh JR. Communication development in children who receive the cochlear implant younger than 12 months: risks versus benefits. Ear Hear 2007;28: 11SY8.
3. Reefhuis J, Honein MA, Whitney CG, et al. Risk of bacterial meningitis in children with cochlear implants. N Engl J Med 2003;349:435-45. (Pubitemid 36910022)
4. Biernath KR, Reefhuis J, Whitney CG, et al. Bacterial meningitis among children with cochlear implants beyond 24 months after implantation. Pediatrics 2006;117:284-9.
5. Rubin LG, Papsin B, and the Committee on Infectious Diseases and Section on OtolaryngologyYHead and Neck Surgery. Cochlear implants in children: surgical site infections, and prevention and treatment of acute otitis media and meningitis. Pediatrics 2010;126: 381-91.
6. Centers for Disease Control and Prevention. Immunization schedules. Available at: http://www.cdc.gov/vaccines/recs/schedules/default.htm. Accessed June 22, 2010.
7. Centers for Disease Control and Prevention. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among childrenVAdvisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep 2010;59: 258-61. Available at: http://www.cdc.gov/mmwr/preview/ mmwrhtml/ mm5909a2.htm. Accessed June 22, 2010.
8. Centers for Disease Control and Prevention. Invasive pneumococcal disease in children 5 years after conjugate vaccine introductionV eight states, 1998-2005. MMWR Morb Mortal Wkly Rep 2008;57; 144-8.
9. Centers for Disease Control and Prevention. ACIP Provisional Recommendations for the Use of Influenza Vaccines. March 2, 2010. Available at: http://www.cdc.gov/vaccines/recs/provisional/ downloads/flu-vac-mar-2010-508. pdf. Accessed June 22, 2010
10. Ozgur SK, Beyazova U, Kemaloglu YK, et al. Effectiveness of inactivated influenza vaccine for prevention of otitis media in children. Pediatr Infect Dis J 2006;25:401-4
11. American Academy of Pediatrics, Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics 2004;113:1451-65.